Trials / Sponsors / Professor Francois Venter
Professor Francois Venter
Academic / Other · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF Compared to DTG/TAF/FTC in Participants Infected Wi HIV-1-infection | Phase 3 | 2023-11-08 |
| Active Not Recruiting | Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South Africa HIV Infection | Phase 4 | 2023-05-19 |
| Unknown | ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavire HIV-1-infection | Phase 3 | 2021-02-09 |
| Completed | DORA: A Doravirine-based First-line Antiretroviral Therapy for Women of Reproductive Potential Living With HIV HIV-1-infection | Phase 3 | 2021-01-04 |
| Completed | The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coa HIV-1-infection, Tuberculosis | Phase 1 | 2019-12-05 |
| Completed | ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy HIV-1 Infection | Phase 3 | 2017-01-16 |